Cargando…
SUPPORT-AF IV: Supporting use of AC through provider prompting about oral anticoagulation therapy for AF clinical trial study protocol
BACKGROUND: Six million Americans suffer from atrial fibrillation (AF), a heart rhythm abnormality that significantly increases the risk of stroke. AF is responsible for 15% of ischemic strokes, which lead to permanent disability in 60% of cases and death in up to 20%. Anticoagulation (AC) is the ma...
Autores principales: | Patel, Jay, Sadiq, Hammad, Catanzaro, John, Crawford, Sybil, Wright, Adam, Manning, Gordon, Allison, Jeroan, Mazor, Kathleen, McManus, David, Kapoor, Alok |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890051/ https://www.ncbi.nlm.nih.gov/pubmed/35265912 http://dx.doi.org/10.1016/j.cvdhj.2021.06.001 |
Ejemplares similares
-
SUPPORT‐AF: Piloting a Multi‐Faceted, Electronic Medical Record‐Based Intervention to Improve Prescription of Anticoagulation
por: Kapoor, Alok, et al.
Publicado: (2018) -
Disparities in Anticoagulation Use by Race and Ethnicity in Long‐Term Care Residents With Atrial Fibrillation
por: Kapoor, Alok, et al.
Publicado: (2021) -
Edoxaban Management in Diagnostic and Therapeutic Procedures (EMIT‐AF/VTE)—Trial design
por: Colonna, Paolo, et al.
Publicado: (2018) -
Electrographic flow–guided ablation in redo patients with persistent atrial fibrillation (FLOW-AF): design and rationale
por: Szili-Torok, Tamas, et al.
Publicado: (2023) -
Improving outcomes of AF ablation by integrated personalized lifestyle interventions: rationale and design of the prevention to improve outcomes of PVI (POP) trial
por: Vermeer, Jasper, et al.
Publicado: (2023)